Posted by
Shannon Weidemann
November 11, 2007 4:25 PM
An antibleeding drug used during heart surgery has been pulled from the market amidst concerns it may harm more than it helps. Bayer is the maker of recalled Trasylol. The drug may be responsible for a higher risk of kidney failure, heart attack and stroke. Trasylol is supposed to reduce blood loss and allow patients undergoing heart-bypass surgery to avoid transfusions. The FDA and...